Arkolith/Insider Trading/DTIL/Form 4

Kelly John Alexander

Chief Financial OfficerPRECISION BIOSCIENCES INC (DTIL) · full profile →Form 4 · filed Jan 22, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$61K
Net Open-Market Flow
-$61K
Transactions
7
4 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 21, 2026Sell(S)15K$4.03$61K106K
Jan 20, 2026Option exercise(M)27K——122K
Jan 20, 2026Option exercise(M)4K——81K
Jan 20, 2026Option exercise(M)14K——95K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 20, 2026Option exercise(M)27K—$027K
Jan 20, 2026Option exercise(M)14K—$014K
Jan 20, 2026Option exercise(M)4K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-003147) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for PRECISION BIOSCIENCES INC

Build

Ask your agent about DTIL insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001628280-26-003147"
Ask your agent
Use Arkolith to summarize insider buying and selling at PRECISION BIOSCIENCES INC
over the last 90 days and cite the filings.